The results suggest superior accumulation and retention of albumin-bound FHAB within the tumor, whether used alone or when linked to anti-TGFβ, and provided POC for increased immunotherapeutic efficacy of payloads linked to the FHAB. The gene discussed is ALB; the disease is neoplasm.